These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 22112539

  • 21. Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis.
    Al-Sha'er MA, Khanfar MA, Taha MO.
    J Mol Model; 2014 Jan; 20(1):2080. PubMed ID: 24469103
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassay.
    Al-Sha'er MA, Taha MO.
    Eur J Med Chem; 2010 Sep; 45(9):4316-30. PubMed ID: 20638755
    [Abstract] [Full Text] [Related]

  • 26. Discovery of novel potent nuclear factor kappa-B inhibitors (IKK-β) via extensive ligand-based modeling and virtual screening.
    Al-Sha'er MA, Almazari IS, Taha MO.
    J Mol Recognit; 2017 Jun; 30(6):. PubMed ID: 28008665
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Discovery of new human epidermal growth factor receptor-2 (HER2) inhibitors for potential use as anticancer agents via ligand-based pharmacophore modeling.
    Zalloum H, Tayyem R, Irmaileh BA, Bustanji Y, Zihlif M, Mohammad M, Rjai TA, Mubarak MS.
    J Mol Graph Model; 2015 Sep; 61():61-84. PubMed ID: 26188796
    [Abstract] [Full Text] [Related]

  • 29. Pharmacophore and QSAR Modeling of Neuronal Nitric Oxide Synthase Ligands and Subsequent Validation and In Silico Search for New Scaffolds.
    Suaifan G, Shehadeh M, Al-Ijel H, Al-Jamal KT, Taha M.
    Med Chem; 2016 Sep; 12(4):371-93. PubMed ID: 26427928
    [Abstract] [Full Text] [Related]

  • 30. Ligand Based Pharmacophore Modeling Followed by Biological Screening Lead to Discovery of Novel PDK1 Inhibitors as Anticancer Agents.
    Mansi I, Al-Sha'er MA, Mhaidat N, Taha M.
    Anticancer Agents Med Chem; 2020 Sep; 20(4):476-485. PubMed ID: 31889497
    [Abstract] [Full Text] [Related]

  • 31. Structure and activity relationship of 2-(substituted benzoyl)-hydroxyindoles as novel CaMKII inhibitors.
    Komiya M, Asano S, Koike N, Koga E, Igarashi J, Nakatani S, Isobe Y.
    Bioorg Med Chem Lett; 2011 Mar 01; 21(5):1456-8. PubMed ID: 21292482
    [Abstract] [Full Text] [Related]

  • 32. Discovery of Potent Bruton's Tyrosine Kinase Inhibitors Using Ligand Based Modeling.
    Mera WA, Alzihlif M, Taha MO, Khanfar MA.
    Anticancer Agents Med Chem; 2017 Mar 01; 17(2):265-275. PubMed ID: 27671297
    [Abstract] [Full Text] [Related]

  • 33. Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads.
    Habash M, Taha MO.
    Bioorg Med Chem; 2011 Aug 15; 19(16):4746-71. PubMed ID: 21788139
    [Abstract] [Full Text] [Related]

  • 34. Discovery of new antifungal leads via pharmacophore modeling and QSAR analysis of fungal N-myristoyl transferase inhibitors followed by in silico screening.
    Taha MO, Qandil AM, Al-Haraznah T, Khalaf RA, Zalloum H, Al-Bakri AG.
    Chem Biol Drug Des; 2011 Sep 15; 78(3):391-407. PubMed ID: 21679375
    [Abstract] [Full Text] [Related]

  • 35. Discovery of new β-D-glucosidase inhibitors via pharmacophore modeling and QSAR analysis followed by in silico screening.
    Abu Khalaf R, Abdula AM, Mubarak MS, Taha MO.
    J Mol Model; 2011 Mar 15; 17(3):443-64. PubMed ID: 20490878
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling.
    Aboalhaija NH, Zihlif MA, Taha MO.
    Chem Biol Interact; 2016 Apr 25; 250():12-26. PubMed ID: 26954606
    [Abstract] [Full Text] [Related]

  • 38. Ligand-based computational modelling of platelet-derived growth factor beta receptor leading to new angiogenesis inhibitory leads.
    Al-Aqtash RA, Zihlif MA, Hammad H, Nassar ZD, Meliti JA, Taha MO.
    Comput Biol Chem; 2017 Dec 25; 71():170-179. PubMed ID: 29101826
    [Abstract] [Full Text] [Related]

  • 39. QSAR studies on aminothiazole derivatives as aurora a kinase inhibitors.
    Qin J, Xi L, Du J, Liu H, Yao X.
    Chem Biol Drug Des; 2010 Dec 25; 76(6):527-37. PubMed ID: 21040493
    [Abstract] [Full Text] [Related]

  • 40. Discovery of potent NEK2 inhibitors as potential anticancer agents using structure-based exploration of NEK2 pharmacophoric space coupled with QSAR analyses.
    Khanfar MA, Banat F, Alabed S, Alqtaishat S.
    Mol Divers; 2017 Feb 25; 21(1):187-200. PubMed ID: 27599492
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.